Period of time： 2001年4期
Publisher： Springer Publishing Company
Founded in： 1978
Total resources： 46
ISSN： 0344-5704
Subject： R73 Oncology
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Cancer Chemotherapy and Pharmacology,volume 47,issue 4
Menu
By Guemei Aida A.,Cottrell Jeff,Band Roger,Hehman Hilary,Prudhomme Mike,Pavlov Michael V.,Grem Jean L.,Ismail Abdel Salam,Bowen Donnell,Taylor Robert E.,Takimoto Chris H. in (2001)
Cancer Chemotherapy and Pharmacology,volume 47,issue 4 , Vol. 47, Iss. 4, 2001-04 , pp.
Access to resources
Recommend
By Egorin Merrill J.,Zuhowski Eleanor G.,Rosen D. Marc,Sentz Dorothy L.,Covey Joseph M.,Eiseman Julie L. in (2001)
Cancer Chemotherapy and Pharmacology,volume 47,issue 4 , Vol. 47, Iss. 4, 2001-04 , pp.Cytocidal effect and DNA damage of nedaplatin in vitro by simulating pharmacokinetic parameters
By Kawanishi Kunihiro,Miyagi Yasunari,Yamamoto Junko,Miyagi Yuji,Nakamura Keiichiro,Kodama Junichi,Hongo Atsushi,Yoshinouchi Mitsuo,Kudo Takafumi in (2001)
Cancer Chemotherapy and Pharmacology,volume 47,issue 4 , Vol. 47, Iss. 4, 2001-04 , pp.Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles
By van Zuylen Lia,Karlsson Mats O.,Verweij Jaap,Brouwer Eric,de Bruijn Peter,Nooter Kees,Stoter Gerrit,Sparreboom Alex in (2001)
Cancer Chemotherapy and Pharmacology,volume 47,issue 4 , Vol. 47, Iss. 4, 2001-04 , pp.By Zhou Shufeng,Paxton James W.,Kestell Philip,Tingle Malcolm D.,Ching Lai-Ming in (2001)
Cancer Chemotherapy and Pharmacology,volume 47,issue 4 , Vol. 47, Iss. 4, 2001-04 , pp.By Morgan Jr Robert J.,Synold Timothy,Carr Brian I.,Doroshow James H.,Womack Eleanor P.,Shibata Stephen,Somlo George,Raschko James,Leong Lucille,McNamara Mark,Chow Warren,Tetef Merry,Margolin Kim,Akman Steven,Longmate Jeff in (2001)
Cancer Chemotherapy and Pharmacology,volume 47,issue 4 , Vol. 47, Iss. 4, 2001-04 , pp.A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day schedule
By Fyfe D.,Price C.,Langley R.E.,Pagonis C.,Houghton J.,Osborne L.,Woll P.J.,Gardner C.,Baguley B.C.,Carmichael J. in (2001)
Cancer Chemotherapy and Pharmacology,volume 47,issue 4 , Vol. 47, Iss. 4, 2001-04 , pp.The enhancement of riboflavin-mediated photo-oxidation of doxorubicin by histidine and urocanic acid
By Ramu Avner,Mehta Michelle M.,Leaseburg Thaddeus,Aleksic Aleksandar in (2001)
Cancer Chemotherapy and Pharmacology,volume 47,issue 4 , Vol. 47, Iss. 4, 2001-04 , pp.By Malingré Mirte M.,Beijnen Jos H.,Rosing Hilde,Koopman Franciska J.,van Tellingen Olaf,Duchin Ken,Ten Bokkel Huinink Wim W.,Swart Martha,Lieverst Jan,Schellens Jan H.M. in (2001)
Cancer Chemotherapy and Pharmacology,volume 47,issue 4 , Vol. 47, Iss. 4, 2001-04 , pp.PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential
By Della Torre Paola,Podestà Arturo,Imondi Anthony R.,Moneta Donatella,Sammartini Umberto,Arrigoni Claudio,Terron Andrea,Brughera Marco in (2001)
Cancer Chemotherapy and Pharmacology,volume 47,issue 4 , Vol. 47, Iss. 4, 2001-04 , pp.
Previous
Next